Microbio (4128) has delivered a -29.07% change over the past year, with a 52-week range between 16.20 and 30.30. What Is the Average Daily Trading Volume of Microbio (4128)? The average daily trading ...

TAIPEI, March 17, 2025 /PRNewswire/ -- Microbio Co., Ltd. (TPEx: 4128) today announced promising results from an exploratory clinical trial assessing MS-20 in combination with current medications for ...

Aaaa Aaa 1,465.6 +28.16% 1,878.3 Aaaaa Aaaaaaaaaaaa 1,850.5 +27.85% 2,365.9 A Aaa A 5,030.0 +22.65% 6,169.3 ...

Please provide your email address to receive an email when new articles are posted on . Leo Pharma, Oneness Biotech and Microbio Shanghai have entered into a worldwide exclusive licensing agreement ...

BRISBANE, Australia, Nov. 29, 2024 /PRNewswire/ -- Microbio Ltd, the Australian pathogen diagnostics company specialising in innovative molecular diagnostic solutions, has appointed Paul Brennan as ...

Leo Pharma is paying $40 million upfront and $530 million in biobucks to license a midstage experimental eczema and asthma drug. The therapy, FB825, has been developed by Oneness Biotech and Microbio ...

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced that is has signed a worldwide exclusive licensing agreement with Oneness Biotech (Taiwan, ...

Microbio (Shanghai) Co. Ltd. has synthesized glucagon-like peptide 1 receptor (GLP1R) agonists reported to be useful for the treatment of obesity, type 2 diabetes and nonalcoholic fatty liver disease.

Brisbane medtech scale-up Microbio has developed a game-changing pathogen test to help identify “a silent killer” that is notoriously difficult to predict, diagnose and treat, as the signs and ...

4147.TWO TaiMed Biologics Inc.

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer ...